See more : Nouveau Life Pharmaceuticals, Inc. (NOUV) Income Statement Analysis – Financial Results
Complete financial analysis of Nam Liong Global Corporation (5450.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nam Liong Global Corporation, a leading company in the Consumer Cyclical industry within the Consumer Cyclical sector.
- GMO Financial Holdings, Inc. (7177.T) Income Statement Analysis – Financial Results
- Gurit Holding AG (GUR.SW) Income Statement Analysis – Financial Results
- China Fortune Financial Group Limited (0290.HK) Income Statement Analysis – Financial Results
- Porto Seguro S.A. (PSSA3.SA) Income Statement Analysis – Financial Results
- Intelligent Ultrasound Group plc (IUG.L) Income Statement Analysis – Financial Results
Nam Liong Global Corporation (5450.TWO)
About Nam Liong Global Corporation
Nam Liong Global Corporation research and develops textile materials in Taiwan. It offers textile, polymer, functional membrane and laminated fabric, and fastening tape materials. The company provides OBM branding and OEM manufacturing services. Nam Liong Global Corporation was founded in 1972 and is based in Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.41B | 3.08B | 3.36B | 2.68B | 2.91B | 2.92B | 697.75M | 752.16M |
| Cost of Revenue | 1.81B | 2.32B | 2.53B | 2.05B | 2.20B | 2.27B | 494.99M | 553.07M |
| Gross Profit | 605.09M | 760.16M | 822.46M | 629.24M | 709.79M | 658.96M | 202.76M | 199.09M |
| Gross Profit Ratio | 25.09% | 24.66% | 24.50% | 23.52% | 24.35% | 22.53% | 29.06% | 26.47% |
| Research & Development | 74.14M | 90.10M | 88.81M | 69.40M | 75.00M | 72.10M | 39.73M | 44.86M |
| General & Administrative | 355.27M | 410.03M | 399.62M | 319.96M | 344.66M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 153.38M | 181.16M | 192.84M | 176.45M | 181.17M | 0.00 | 0.00 | 0.00 |
| SG&A | 508.65M | 530.15M | 544.69M | 445.30M | 485.86M | 468.24M | 140.83M | 143.79M |
| Other Expenses | 0.00 | 25.14M | 29.29M | 22.71M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 586.12M | 620.25M | 633.50M | 514.70M | 560.85M | 540.34M | 180.56M | 188.65M |
| Cost & Expenses | 2.39B | 2.94B | 3.17B | 2.56B | 2.77B | 2.81B | 675.55M | 741.71M |
| Interest Income | 10.77M | 3.35M | 1.87M | 2.84M | 3.83M | 3.47M | 1.58M | 1.16M |
| Interest Expense | 27.44M | 30.67M | 27.22M | 28.20M | 23.03M | 21.30M | 4.20M | 3.50M |
| Depreciation & Amortization | 120.64M | 113.79M | 101.07M | 95.71M | 84.42M | 63.07M | 20.30M | 20.94M |
| EBITDA | 187.80M | 253.70M | 304.39M | 211.51M | 233.35M | 181.70M | 42.50M | 31.39M |
| EBITDA Ratio | 7.79% | 8.23% | 8.64% | 7.86% | 8.01% | 6.21% | 6.09% | 4.17% |
| Operating Income | 19.41M | 139.91M | 188.96M | 114.54M | 148.93M | 118.63M | 22.20M | 10.45M |
| Operating Income Ratio | 0.80% | 4.54% | 5.63% | 4.28% | 5.11% | 4.06% | 3.18% | 1.39% |
| Total Other Income/Expenses | 20.76M | 51.59M | -14.84M | -26.95M | -34.59M | -88.51M | -2.45M | 15.00M |
| Income Before Tax | 40.17M | 191.50M | 176.09M | 87.59M | 113.83M | 135.52M | 19.76M | 25.44M |
| Income Before Tax Ratio | 1.67% | 6.21% | 5.25% | 3.27% | 3.91% | 4.63% | 2.83% | 3.38% |
| Income Tax Expense | 27.62M | 13.88M | 25.84M | 21.12M | 43.42M | 49.86M | 19.92M | 20.39M |
| Net Income | 12.55M | 177.62M | 150.26M | 66.47M | 70.93M | -19.74M | -165.00K | 5.06M |
| Net Income Ratio | 0.52% | 5.76% | 4.48% | 2.48% | 2.43% | -0.68% | -0.02% | 0.67% |
| EPS | 0.10 | 1.45 | 1.23 | 0.54 | 0.58 | -0.39 | 0.00 | 0.10 |
| EPS Diluted | 0.09 | 1.44 | 1.22 | 0.54 | 0.58 | -0.39 | 0.00 | 0.10 |
| Weighted Avg Shares Out | 122.39M | 122.39M | 122.39M | 122.39M | 122.39M | 50.39M | 50.39M | 50.39M |
| Weighted Avg Shares Out (Dil) | 144.09M | 123.40M | 123.03M | 122.39M | 122.39M | 50.39M | 50.39M | 50.39M |
Source: https://incomestatements.info
Category: Stock Reports